AAL vs CELU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 26, 2026

AAL

61.8
AI Score
VS
AAL Wins

CELU

33.4
AI Score

Investment Advisor Scores

AAL

62score
Recommendation
BUY

CELU

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAL CELU Winner
Revenue 30.65B 22.45M AAL
Net Income -311.00M -67.35M CELU
Net Margin -1.0% -300.1% AAL
Operating Income 405.00M -39.25M AAL
ROE 7.8% 335.2% CELU
ROA -0.5% -59.0% AAL
Total Assets 64.23B 114.24M AAL
Cash 1.03B 120,000 AAL
Current Ratio 0.53 0.16 AAL

Relative Price Performance (Last 90 Days)

AAL 1M: -7.5% · 3M: -6.3% CELU 1M: +213.4% · 3M: +111.9%

Current Technical Phase

AAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.7 · Price: $13.72

CELU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 93

RSI (14): 92.6 · Price: $2.10

Fundamentals Snapshot

Metric AAL CELU
Market Cap
Forward P/E 5.9 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.2% -0.8%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% -4.9%
EPS -0.49 -3.95
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, AAL is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.